Skip to main content

View full-text article in PMC

. 2018 Dec 4;6:2050312118816919. doi: 10.1177/2050312118816919

Table 2.

Outcomes at 6 and 12 months by treatment group.

	6-month outcome			12-month outcome
	Single-tablet regimens (n = 103)	Multiple-tablet regimens (n = 115)	P-value^a	Single-tablet regimens (n = 74)	Multiple-tablet regimens (n = 95)	P-value^a
# undetectable VL (95% CI)	79 (77%)	70 (61%)	0.012	61 (82%)	63 (66%)	0.019
Median CD4 count, mm³ (IQR)	407 (332)	326 (319)	0.045	477 (339)	389 (309)	0.166
Median change in CD4, mm³ (IQR)	+121 (124)	+121 (172)	0.39	+180 (219)	+165 (224)	0.52

VL, viral load; CI, confidence interval; IQR, interquartile range.

^a

Using the Pearson chi-square test for undetectable VL and Wilcoxon rank-sum for median CD4 and change in CD4.

Bold value represents an alpha of 0.05.